| Matthew Lindemann, MD | |
|
4001 Dale St, Ste #105, Anchorage, AK 99508-5428 | |
| (907) 222-9930 | |
| (907) 222-9931 |
| Full Name | Matthew Lindemann |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 26 Years |
| Location | 4001 Dale St, Anchorage, Alaska |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1376530170 | NPI | - | NPPES |
| MD2323 | Medicaid | AK |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 4878 (Alaska) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Alaska Regional Hospital | Anchorage, AK | Hospital |
| Providence Alaska Medical Center | Anchorage, AK | Hospital |
| Entity Name | Providence Health & Services- Washington |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093956278 PECOS PAC ID: 1557408176 Enrollment ID: O20091029000679 |
News Archive
Hormone treatment to halt puberty in adolescents with gender identity disorder does not cause lasting harm to their bones, a new study finds. The results were presented today at The Endocrine Society's 95th Annual Meeting in San Francisco.
In a new BJU International study, women with urinary incontinence reported declines in sexual activity and arousal over the last year, and they expressed increased concern about their frequency of sexual activity and ability to become sexually aroused. Men with urinary incontinence reported declines in sexual desire, increased erectile and orgasm difficulties, and concern about these sexual functions.
More than two-thirds of children from low-income Latino families don't receive adequate pain control when they go home after surgery, according to a study being presented at the ANESTHESIOLOGY 2014 annual meeting.
Why can't Americans tap into the ingenuity that put men on the moon, created the Internet and sequenced the human genome to revitalize our economy? I'm convinced we can. We are in the early phases of the next big technology-driven revolution, which I call "consumer health." When fully unleashed, it could radically cut health care costs and become a huge global growth market.
Zalicus Inc., a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain and immuno-inflammatory diseases, today announced that it has initiated the first of two Phase 2a clinical studies with Z160, its first-in-class, oral, state-dependent, selective N-type calcium channel blocker for the treatment of chronic neuropathic pain indications.
› Verified 6 days ago
| Entity Name | Borealis Life Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1700591831 PECOS PAC ID: 1052770419 Enrollment ID: O20230702000061 |
News Archive
Hormone treatment to halt puberty in adolescents with gender identity disorder does not cause lasting harm to their bones, a new study finds. The results were presented today at The Endocrine Society's 95th Annual Meeting in San Francisco.
In a new BJU International study, women with urinary incontinence reported declines in sexual activity and arousal over the last year, and they expressed increased concern about their frequency of sexual activity and ability to become sexually aroused. Men with urinary incontinence reported declines in sexual desire, increased erectile and orgasm difficulties, and concern about these sexual functions.
More than two-thirds of children from low-income Latino families don't receive adequate pain control when they go home after surgery, according to a study being presented at the ANESTHESIOLOGY 2014 annual meeting.
Why can't Americans tap into the ingenuity that put men on the moon, created the Internet and sequenced the human genome to revitalize our economy? I'm convinced we can. We are in the early phases of the next big technology-driven revolution, which I call "consumer health." When fully unleashed, it could radically cut health care costs and become a huge global growth market.
Zalicus Inc., a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain and immuno-inflammatory diseases, today announced that it has initiated the first of two Phase 2a clinical studies with Z160, its first-in-class, oral, state-dependent, selective N-type calcium channel blocker for the treatment of chronic neuropathic pain indications.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Matthew Lindemann, MD 4001 Dale St, Ste #105, Anchorage, AK 99508-5428 Ph: (907) 222-9930 | Matthew Lindemann, MD 4001 Dale St, Ste #105, Anchorage, AK 99508-5428 Ph: (907) 222-9930 |
News Archive
Hormone treatment to halt puberty in adolescents with gender identity disorder does not cause lasting harm to their bones, a new study finds. The results were presented today at The Endocrine Society's 95th Annual Meeting in San Francisco.
In a new BJU International study, women with urinary incontinence reported declines in sexual activity and arousal over the last year, and they expressed increased concern about their frequency of sexual activity and ability to become sexually aroused. Men with urinary incontinence reported declines in sexual desire, increased erectile and orgasm difficulties, and concern about these sexual functions.
More than two-thirds of children from low-income Latino families don't receive adequate pain control when they go home after surgery, according to a study being presented at the ANESTHESIOLOGY 2014 annual meeting.
Why can't Americans tap into the ingenuity that put men on the moon, created the Internet and sequenced the human genome to revitalize our economy? I'm convinced we can. We are in the early phases of the next big technology-driven revolution, which I call "consumer health." When fully unleashed, it could radically cut health care costs and become a huge global growth market.
Zalicus Inc., a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain and immuno-inflammatory diseases, today announced that it has initiated the first of two Phase 2a clinical studies with Z160, its first-in-class, oral, state-dependent, selective N-type calcium channel blocker for the treatment of chronic neuropathic pain indications.
› Verified 6 days ago
Dr. Wendy Sue Cruz, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2741 Debarr Rd Ste C205, Anchorage, AK 99508 Phone: 907-279-2273 Fax: 907-258-7705 | |
Dr. James Thomas Barber Jr., D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3831 Piper St Ste Sll020, Anchorage, AK 99508 Phone: 907-212-3470 Fax: 907-212-3474 | |
Dr. Natalie Dawn Ward, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3260 Providence Dr, Ste. #425, Anchorage, AK 99508 Phone: 907-561-7111 Fax: 907-770-7891 | |
Tania H Hall, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3260 Providence Dr, Ste 322, Anchorage, AK 99508 Phone: 907-563-5151 Fax: 907-563-6278 | |
Anne Gray, Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 4141 Ambassador Dr, Anchorage, AK 99508 Phone: 907-729-1542 | |
Mrs. Kristin M Murray, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 4115 Lake Otis Pkwy, Anchorage, AK 99508 Phone: 907-563-7228 Fax: 907-563-6278 | |
Kathryn Murphy, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 4320 Diplomacy Dr, Anchorage, AK 99508 Phone: 907-729-3116 |